JP2003516957A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003516957A5 JP2003516957A5 JP2001544659A JP2001544659A JP2003516957A5 JP 2003516957 A5 JP2003516957 A5 JP 2003516957A5 JP 2001544659 A JP2001544659 A JP 2001544659A JP 2001544659 A JP2001544659 A JP 2001544659A JP 2003516957 A5 JP2003516957 A5 JP 2003516957A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- active ingredient
- composition
- premix
- neutralizing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical group OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR99/15763 | 1999-12-14 | ||
| FR9915763A FR2802097B1 (fr) | 1999-12-14 | 1999-12-14 | Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication |
| PCT/FR2000/003533 WO2001043720A1 (fr) | 1999-12-14 | 2000-12-14 | Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003516957A JP2003516957A (ja) | 2003-05-20 |
| JP2003516957A5 true JP2003516957A5 (https=) | 2008-01-31 |
Family
ID=9553244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001544659A Pending JP2003516957A (ja) | 1999-12-14 | 2000-12-14 | 特に粘膜塗布用の溶液又は懸濁状の有効成分を入れるためのゲル形状組成物及び製造方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030091642A1 (https=) |
| EP (1) | EP1237537B1 (https=) |
| JP (1) | JP2003516957A (https=) |
| AT (1) | ATE336987T1 (https=) |
| AU (1) | AU2525601A (https=) |
| CA (1) | CA2394416A1 (https=) |
| CY (1) | CY1106249T1 (https=) |
| DE (1) | DE60030319T2 (https=) |
| DK (1) | DK1237537T3 (https=) |
| ES (1) | ES2270895T3 (https=) |
| FR (1) | FR2802097B1 (https=) |
| PT (1) | PT1237537E (https=) |
| WO (1) | WO2001043720A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20031640A1 (it) | 2003-08-08 | 2005-02-09 | Mipharm S P A | Base per gel bioadesivi. |
| US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
| AU2004274000B2 (en) * | 2003-09-19 | 2009-07-30 | Drugtech Corporation | Pharmaceutical delivery system |
| US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
| CA2605341A1 (en) * | 2005-05-09 | 2006-11-16 | Drugtech Corporation | Modified-release pharmaceutical compositions |
| CN101374501A (zh) * | 2006-01-05 | 2009-02-25 | 药物技术公司 | 组合物及其使用方法 |
| US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
| EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| JP2533723B2 (ja) * | 1992-12-28 | 1996-09-11 | 東興薬品工業株式会社 | 速乾性ゲルタイプ手指消毒剤 |
| ES2078175B1 (es) * | 1993-12-31 | 1996-10-16 | Cusi Lab | Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones. |
| US5902110A (en) * | 1995-12-18 | 1999-05-11 | The Block Drug Company | Bone regeneration |
| US5869601A (en) * | 1996-04-05 | 1999-02-09 | S. C. Johnson & Son, Inc. | Method of stabilizing the viscosity of a thickened composition |
| EP1011609A4 (en) * | 1997-05-09 | 2000-08-16 | Medlogic Global Corp | COMPOSITIONS FOR COSMETIC APPLICATIONS |
| US7064114B2 (en) * | 1999-03-19 | 2006-06-20 | Parker Hughes Institute | Gel-microemulsion formulations |
-
1999
- 1999-12-14 FR FR9915763A patent/FR2802097B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-14 ES ES00988913T patent/ES2270895T3/es not_active Expired - Lifetime
- 2000-12-14 WO PCT/FR2000/003533 patent/WO2001043720A1/fr not_active Ceased
- 2000-12-14 DE DE60030319T patent/DE60030319T2/de not_active Expired - Lifetime
- 2000-12-14 DK DK00988913T patent/DK1237537T3/da active
- 2000-12-14 AT AT00988913T patent/ATE336987T1/de active
- 2000-12-14 JP JP2001544659A patent/JP2003516957A/ja active Pending
- 2000-12-14 EP EP00988913A patent/EP1237537B1/fr not_active Expired - Lifetime
- 2000-12-14 CA CA002394416A patent/CA2394416A1/fr not_active Abandoned
- 2000-12-14 US US10/149,695 patent/US20030091642A1/en not_active Abandoned
- 2000-12-14 PT PT00988913T patent/PT1237537E/pt unknown
- 2000-12-14 AU AU25256/01A patent/AU2525601A/en not_active Abandoned
-
2006
- 2006-11-16 CY CY20061101679T patent/CY1106249T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Acarturk | Mucoadhesive vaginal drug delivery systems | |
| EP1263411B1 (en) | Compositions and use thereof for trapping and inactivating pathogenic microbes and spermatozoa | |
| NO20001567D0 (no) | Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler | |
| RU97109845A (ru) | Противогеморройные композиции и способ применения | |
| CA2424346A1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome | |
| RU2560879C2 (ru) | Cпособ профилактики передающихся половым путем вирусных заболеваний, лекарственное средство, способ получения лекарственного средства, фармацевтическая композиция для местного применения и презерватив | |
| ATE237330T1 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
| JPH09510468A (ja) | 皮膚疾患の治療のための及びその皮膚の消毒のためのゲル | |
| KR20110125660A (ko) | 가온성 및 무자극성 윤활제 항진균성 겔 조성물 | |
| JP2004514731A (ja) | 眼薬送達のための可逆的ゲル化システム | |
| EP0966966A3 (en) | Nefazodone dosage form | |
| JP2001513545A5 (https=) | ||
| PL402549A1 (pl) | Dopochwowa kompozycja farmaceutyczna i zastosowanie | |
| CA2450359A1 (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| WO2018012595A1 (ja) | 害虫忌避組成物、及び害虫忌避方法 | |
| PT1079790E (pt) | Utilizacao de composicoes microbicidas e espermicidas para inactivacao de virus sem envelope | |
| JP2003516957A5 (https=) | ||
| MXPA04005783A (es) | Formulacion farmaceutica que comprende ciclosporina y uso de la misma. | |
| PL1651274T3 (pl) | Żel bioadhezyjny na bazie hydroksyetylocelulozy | |
| JP2005518435A5 (https=) | ||
| JP2002114711A (ja) | 外用剤組成物 | |
| CA2272732A1 (en) | Hemorrhoidal treatment composition | |
| CA2502582A1 (en) | Pharmaceutical formulation of olanzapine | |
| NZ521533A (en) | Veterinary compositions for the treatment of parasitic diseases containing rafoxanide | |
| AU2001228513A1 (en) | Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant |